Home » Topics » Conferences, BioWorld Science

Conferences, BioWorld Science
RSS

Selective 5-HT2C antagonist selected for development at Organon

Sep. 17, 1998

Japanese and Dutch scientists design LTD4 and dual LTD4/H1 antagonists

Sep. 17, 1998

Merck KGaA discovers potent dual 5-HT1A antagonist and 5-HT reuptake inhibitor

Sep. 16, 1998

SKB selects V-ATPase inhibitor SB-242784 for further evaluation

Sep. 16, 1998

S-23751: new 5-HT1A/5-HT7 receptor ligand with anxiolytic activity

Sep. 16, 1998

Design and synthesis of cycloheptylurea factor Xa inhibitors reported by DuPont

Sep. 16, 1998

Organon designs novel acylguanidine-containing thrombin inhibitors

Sep. 16, 1998

Potent and selective 5-HT1B/1D antagonists designed by Merck KGaA

Sep. 16, 1998

Novel glucagon receptor antagonist with potential in treating type I/type II diabetes

Sep. 15, 1998

Pierre Fabre describes pharmacological profile of F-11440 -- new high-efficacy 5-HT1A agonist

Sep. 15, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...